MicroPort NeuroScientific

What MicroPort NeuroScientific does

MicroPort NeuroScientific, operating as MicroPort NeuroTech Limited, is a Shanghai-headquartered medical device company specializing in neurovascular interventional products for the treatment of stroke and cerebral aneurysms. The company develops and manufactures a comprehensive portfolio of devices organized around three clinical pathways: hemorrhagic stroke (Tubridge™ flow-diverting stents, NUMEN™ embolization coils with Frame/Fill/Finish/Silk variants), acute ischemic stroke (Apollo™ intracranial arterial stent, NeuroHawk™, X-track™ catheters), and intracranial atherosclerosis (Bridge™ rapamycin-eluting vertebral artery stent). Additional platforms include balloon catheters (DIVEER™, PathFinder™), the Willis™ intracranial stent, and the novel PCAR pressure-guided coiling system developed through academic-clinical partnerships.

The company serves neurointerventional hospitals, stroke centers, and interventional neuroradiology specialists globally, with 20 approved products distributed across 16 international markets. It operates through direct enterprise field sales to hospitals, supported by five regional offices in Shanghai (headquarters), Irvine (USA), São Paulo (Brazil), London (UK), and Amsterdam (Netherlands). Commercial reach is extended through active participation in major neurointerventional conferences (WLNC, ESMINT, ESNR, LINNC) and the MindShare physician education program. Revenue is generated through hardware sales of medical devices via standard hospital procurement contracts; pricing is not publicly disclosed. The company is publicly listed on the Hong Kong Stock Exchange under ticker 02172.HK and was named one of Shanghai's Top 100 Specialized and Sophisticated Enterprises 2024. 2024 was an active commercial year, with NUMEN™ Coil market entry into France, first Tubridge™ implantation in Brazil, NMPA authorization for PathFinder™, and the world's first clinical application of the PCAR system.

Name

MicroPort NeuroScientific

Legal name

MicroPort NeuroTech Limited

Website

https://microportneuro.com

Company type

Public

Founded year

2024

Operating status

Operating

Headcount range

501–1,000 employees

Short description

MicroPort NeuroScientific is a Shanghai-headquartered medical device company developing neurovascular interventional products — including intracranial stents, embolization coils, flow-diverting stents, and balloon catheters — for treating stroke and cerebral aneurysms, selling to hospitals and neurointerventional specialists across 16 international markets.

Ownership category

akta.pro rank

Product category

Neurovascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHAFAJ

Thrombectomy, Embolic Protection & Stroke Intervention Devices

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

• Neurovascular medical devices
• Intracranial stents
• Embolization coils
• Flow diversion devices
• Balloon catheters

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Neurovascular Device Sales: MicroPort NeuroScientific generates revenue through the sale of neurovascular medical devices including stents, coils, catheters, and access systems to hospitals and healthcare providers worldwide.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

MicroPort NeuroScientific develops, manufactures, and commercializes neurovascular interventional medical devices for the treatment of acute ischemic stroke, hemorrhagic stroke, and intracranial atherosclerosis. Its portfolio spans intracranial stents (Apollo™, NeuroHawk™, Willis™), flow-diverting stents (Tubridge™), embolization coils (NUMEN™ family), balloon catheters (DIVEER™, PathFinder™), distal access and microcatheters (X-track™), drug-eluting vertebral artery stents (Bridge™), and the proprietary PCAR pressure-guided coiling system. Products are sold directly to hospitals, stroke centers, and interventional neuroradiology specialists across 16 international markets.

Product overview

MicroPort NeuroScientific is a medical device company specializing in neurovascular interventional products for stroke treatment and related cerebrovascular conditions. The company offers a comprehensive portfolio of neurovascular stents, flow-diverting devices, embolization coils, and balloon catheters. The product portfolio includes the Apollo™ Intracranial Arterial Stent System, Tubridge™ and Tubridge™ Plus flow-diverting stents, the NUMEN™ Embolization Coil family (including Frame, Fill, Finish, and Silk variants), Bridge™ drug-eluting vertebral artery stent, NeuroHawk™, X-track™ catheters, DIVEER™ and PathFinder™ balloon catheters, the PCAR system for carotid artery treatment, and Willis™ intracranial stent.

Differentiator

Problem solved

Functional benefit

Brands

• Apollo™: Apollo™ Intracranial Arterial Stent System - a medical device for intracranial arterial treatment
• Tubridge™
• NUMEN™
• Bridge™
• DIVEER™
• NeuroHawk™
• X-track™
• PathFinder™

Products and services

• Apollo™ Intracranial Arterial Stent System Intracranial arterial stent system designed for the treatment of intracranial atherosclerotic disease, used by interventional neuroradiologists and neurosurgeons in hospital catheterization labs.
• Tubridge™ Flow-diverting Stent Flow-diverting stent for the treatment of intracranial aneurysms that redirects blood flow away from the aneurysm sac; available in standard and Tubridge™ Plus enhanced delivery variants. Used by neurointerventional specialists in tertiary hospitals.
• NUMEN™ Embolization Coil Embolization coil system for aneurysm occlusion, available in multiple configurations including Frame (initial framing), Fill (aneurysm filling), Finish (final occlusion), and Silk (advanced mesh design for wide-neck bifurcation aneurysms) variants. Sold to hospitals performing coil embolization procedures.
• Bridge™ Rapamycin Target Eluting Vertebral Artery Stent System Drug-eluting stent system designed for vertebral artery stenosis treatment, releasing rapamycin to reduce restenosis. Used by interventional neuroradiologists and vascular specialists.
• NeuroHawk™ Neurovascular stent system for the treatment of intracranial atherosclerotic disease, used in hospital neurointerventional procedures.
• X-track™ Neurovascular Catheter Neurovascular catheter system for accessing intracranial vessels during interventional procedures, designed for navigating complex neurovascular anatomy. Used as an access and delivery tool in stroke and aneurysm interventions.
• DIVEER™ Intracranial Balloon Catheter Balloon catheter for intracranial vessel dilation and angioplasty procedures, providing temporary support during coil embolization. Sold to hospitals performing neurointerventional procedures.
• PathFinder™ Carotid Balloon Dilation Catheter Balloon dilation catheter designed for carotid artery intervention procedures, specifically for percutaneous transluminal angioplasty in patients with carotid artery occlusive disease. Used by interventional neuroradiologists and vascular surgeons in hospitals.
• PCAR System (Pressure Coiling Assisted coiling for Aneurysm Remodeling) Pressure-guided coiling system (also referred to as Percutaneous Neuroprotection for Carotid Artery Remodelling) for the treatment of cerebral aneurysms using a novel pressure-based architectural approach. Co-developed with leading neurointerventional academic clinical teams.
• Willis™ Intracranial Stent System Intracranial stent system designed for cerebral aneurysm treatment. Used by neurointerventional specialists in tertiary and academic medical centers.

Quantifiable outcome

• 20 products approved across 16 international markets demonstrating regulatory success and global commercial reach

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core and regional.

• Fudan University Affiliated Pudong Medical Center - Prof. Bo Yu's TeamcoreStrategic or Co-development Partner · 1 January 2023Clinical collaboration for development of the PCAR (Pressure Coiling Assisted coiling for Aneurysm Remodeling) system, a revolutionary pressure-guided coiling technology for cerebral aneurysm treatment. The collaboration combines academic research capabilities with clinical expertise to advance neurovascular intervention technology.
• Shanghai Changhai Hospital - Prof. Jianmin Liu's TeamcoreStrategic or Co-development Partner · 1 January 2023Clinical collaboration on PCAR system development, contributing expert clinical insights and real-world surgical experience to refine the pressure-guided coiling technology for commercial deployment.
• Hospital Brasilia - Dr. Bruno ParenteregionalStrategic or Co-development Partner · 1 January 2020Clinical collaboration in Latin America for neurointerventional procedures, supporting clinical evidence generation and physician training in the region for MicroPort NeuroScientific's product portfolio.
• Rothschild Foundation Hospital - Prof. Michel PiotinregionalStrategic or Co-development Partner · 1 January 2020Clinical collaboration in Europe for neurovascular interventions, providing clinical expertise and participating in clinical trials to generate evidence for product efficacy and safety in European markets.

Scale indicators4 records

Expansion highlights6 records

Market position

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/microport-neuroscientific

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MicroPort NeuroScientific